These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30619781)

  • 1. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors.
    El Qaidi S; Zhu C; McDonald P; Roy A; Maity PK; Rane D; Perera C; Hardwidge PR
    Front Cell Infect Microbiol; 2018; 8():435. PubMed ID: 30619781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NleB/SseK effectors from
    El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
    J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YM155 Inhibits NleB and SseK Arginine Glycosyltransferase Activity.
    Zhu C; El Qaidi S; McDonald P; Roy A; Hardwidge PR
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33672424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity.
    Araujo-Garrido JL; Bernal-Bayard J; Ramos-Morales F
    Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32131463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Avasimibe to Inhibit Bacterial Glycosyltransferases.
    Hasan MK; El Qaidi S; McDonald P; Roy A; Hardwidge PR
    Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
    Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
    J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages.
    Günster RA; Matthews SA; Holden DW; Thurston TLM
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.
    Koh E; Kim U; Cho HS
    Sci Rep; 2022 Nov; 12(1):19288. PubMed ID: 36369343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery.
    García-García A; Hicks T; El Qaidi S; Zhu C; Hardwidge PR; Angulo J; Hurtado-Guerrero R
    Chem Sci; 2021 Sep; 12(36):12181-12191. PubMed ID: 34667584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
    Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL
    PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for arginine glycosylation of host substrates by bacterial effector proteins.
    Park JB; Kim YH; Yoo Y; Kim J; Jun SH; Cho JW; El Qaidi S; Walpole S; Monaco S; García-García AA; Wu M; Hays MP; Hurtado-Guerrero R; Angulo J; Hardwidge PR; Shin JS; Cho HS
    Nat Commun; 2018 Oct; 9(1):4283. PubMed ID: 30327479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
    Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
    Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto Arginine-GlcNAcylation Is Crucial for Bacterial Pathogens in Regulating Host Cell Death.
    Xue J; Pan X; Peng T; Duan M; Du L; Zhuang X; Cai X; Yi X; Fu Y; Li S
    Front Cell Infect Microbiol; 2020; 10():197. PubMed ID: 32432056
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Newson JPM; Scott NE; Yeuk Wah Chung I; Wong Fok Lung T; Giogha C; Gan J; Wang N; Strugnell RA; Brown NF; Cygler M; Pearson JS; Hartland EL
    Mol Cell Proteomics; 2019 Jun; 18(6):1138-1156. PubMed ID: 30902834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intra-bacterial activity for a T3SS effector.
    El Qaidi S; Scott NE; Hays MP; Geisbrecht BV; Watkins S; Hardwidge PR
    Sci Rep; 2020 Jan; 10(1):1073. PubMed ID: 31974499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arg-GlcNAcylation on TRADD by NleB and SseK1 Is Crucial for Bacterial Pathogenesis.
    Xue J; Hu S; Huang Y; Zhang Q; Yi X; Pan X; Li S
    Front Cell Dev Biol; 2020; 8():641. PubMed ID: 32766249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteria-Catalyzed Arginine Glycosylation in Pathogens and Host.
    Pan X; Luo J; Li S
    Front Cell Infect Microbiol; 2020; 10():185. PubMed ID: 32411621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the glycosyltransferase activity of the
    Esposito D; Günster RA; Martino L; El Omari K; Wagner A; Thurston TLM; Rittinger K
    J Biol Chem; 2018 Apr; 293(14):5064-5078. PubMed ID: 29449376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SseK1 and SseK2 are novel translocated proteins of Salmonella enterica serovar typhimurium.
    Kujat Choy SL; Boyle EC; Gal-Mor O; Goode DL; Valdez Y; Vallance BA; Finlay BB
    Infect Immun; 2004 Sep; 72(9):5115-25. PubMed ID: 15322005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Functional Insights into Host Death Domains Inactivation by the Bacterial Arginine GlcNAcyltransferase Effector.
    Ding J; Pan X; Du L; Yao Q; Xue J; Yao H; Wang DC; Li S; Shao F
    Mol Cell; 2019 Jun; 74(5):922-935.e6. PubMed ID: 30979585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.